236 related articles for article (PubMed ID: 11156588)
1. Inhibition by glucocorticoids of the mast cell-dependent weal and flare response in human skin in vivo.
Cole ZA; Clough GF; Church MK
Br J Pharmacol; 2001 Jan; 132(1):286-92. PubMed ID: 11156588
[TBL] [Abstract][Full Text] [Related]
2. Prolonged treatment with topical glucocorticoids results in an inhibition of the allergen-induced weal-and-flare response and a reduction in skin mast cell numbers and histamine content.
Pipkorn U; Hammarlund A; Enerbäck L
Clin Exp Allergy; 1989 Jan; 19(1):19-25. PubMed ID: 2649213
[TBL] [Abstract][Full Text] [Related]
3. Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: a study using scanning laser Doppler imaging.
Clough GF; Bennett AR; Church MK
Br J Dermatol; 1998 May; 138(5):806-14. PubMed ID: 9666826
[TBL] [Abstract][Full Text] [Related]
4. Effect of terbutaline and bambuterol on immediate-type allergic skin responses and mediator release in human skin.
Petersen LJ; Skov PS
Inflamm Res; 2003 Sep; 52(9):372-7. PubMed ID: 14504664
[TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor (PAF) induces wheal and flare skin reactions independent of mast cell degranulation.
Krause K; Giménez-Arnau A; Martinez-Escala E; Farré-Albadalejo M; Abajian M; Church MK; Maurer M
Allergy; 2013 Feb; 68(2):256-8. PubMed ID: 23320562
[TBL] [Abstract][Full Text] [Related]
6. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
Sansom JE; Brooks J; Burton JL; Archer CB
Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
[TBL] [Abstract][Full Text] [Related]
7. Effects of topically applied clobetasol-17-propionate on histamine release in human skin.
Ståhle M; Hägermark O
Acta Derm Venereol; 1984; 64(3):239-42. PubMed ID: 6204486
[TBL] [Abstract][Full Text] [Related]
8. The effect of cetirizine and loratadine on codeine-induced histamine release in human skin in vivo assessed by cutaneous microdialysis.
Perzanowska M; Malhotra D; Skinner SP; Rihoux JP; Bewley AP; Petersen LJ; Church MK
Inflamm Res; 1996 Sep; 45(9):486-90. PubMed ID: 8891761
[TBL] [Abstract][Full Text] [Related]
9. Reaction pattern to histamine and codeine in a human intradermal skin test model.
Scherer K; Grize L; Schindler C; Surber C; Bircher AJ
Clin Exp Allergy; 2007 Jan; 37(1):39-46. PubMed ID: 17210040
[TBL] [Abstract][Full Text] [Related]
10. No release of histamine and substance P in capsaicin-induced neurogenic inflammation in intact human skin in vivo: a microdialysis study.
Petersen LJ; Winge K; Brodin E; Skov PS
Clin Exp Allergy; 1997 Aug; 27(8):957-65. PubMed ID: 9291295
[TBL] [Abstract][Full Text] [Related]
11. Blood flow in histamine- and allergen-induced weal and flare responses, effects of an H1 antagonist, alpha-adrenoceptor agonist and a topical glucocorticoid.
Hammarlund A; Olsson P; Pipkorn U
Allergy; 1990 Jan; 45(1):64-70. PubMed ID: 2137995
[TBL] [Abstract][Full Text] [Related]
12. Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in vivo microdialysis study in human skin.
Blunk JA; Schmelz M; Zeck S; Skov P; Likar R; Koppert W
Anesth Analg; 2004 Feb; 98(2):364-370. PubMed ID: 14742371
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor induces histamine release from human skin mast cells in vivo, which is reduced by local nerve blockade.
Petersen LJ; Church MK; Skov PS
J Allergy Clin Immunol; 1997 May; 99(5):640-7. PubMed ID: 9155831
[TBL] [Abstract][Full Text] [Related]
14. Effects of cromolyn on codeine-induced histamine release in vivo.
Ting S; Reimann EF; Zweiman B
Allergy; 1984 Oct; 39(7):493-7. PubMed ID: 6208804
[TBL] [Abstract][Full Text] [Related]
15. Aberrant cutaneous weal and flare responses in chronic urticaria.
Shall L; Saihan EM
Acta Derm Venereol; 1992 Nov; 72(6):451-3. PubMed ID: 1362842
[TBL] [Abstract][Full Text] [Related]
16. The effects of astemizole, cetirizine and loratadine on the time course of weal and flare reactions to histamine, codeine and antigen.
Humphreys F; Hunter JA
Br J Dermatol; 1991 Oct; 125(4):364-7. PubMed ID: 1683252
[TBL] [Abstract][Full Text] [Related]
17. Topical sodium cromoglicate relieves allergen- and histamine-induced dermal pruritus.
Vieira Dos Santos R; Magerl M; Martus P; Zuberbier T; Church MK; Escribano L; Maurer M
Br J Dermatol; 2010 Mar; 162(3):674-6. PubMed ID: 19785618
[TBL] [Abstract][Full Text] [Related]
18. Cetirizine inhibits skin reactions but not mediator release in immediate and developing late-phase allergic cutaneous reactions. A double-blind, placebo-controlled study.
Nielsen PN; Skov PS; Poulsen LK; Schmelz M; Petersen LJ
Clin Exp Allergy; 2001 Sep; 31(9):1378-84. PubMed ID: 11591187
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic dermographism: wealing, mast cells and histamine are decreased in the skin following long-term application of a potent topical corticosteroid.
Lawlor F; Black AK; Murdoch RD; Greaves MW
Br J Dermatol; 1989 Nov; 121(5):629-34. PubMed ID: 2597634
[TBL] [Abstract][Full Text] [Related]
20. Methacholine induces wheal-and-flare reactions in human skin but does not release histamine in vivo as assessed by the skin microdialysis technique.
Petersen LJ; Skov PS
Allergy; 1995 Dec; 50(12):976-80. PubMed ID: 8834827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]